Department of Medicinal Chemistry
The Department of Medicinal Chemistry consists of a diverse group of faculty members, PhD graduate students, postdoctoral fellows and research scientists working at the interface of chemistry and biology.
Areas of research focus in the Department include antiviral drug design, cancer drug discovery and chemoprevention, chemical biology, carcinogenesis, peptidomimetics, receptor modeling, drug metabolism, gene therapy, combinatorial biosynthesis, natural product chemistry and NMR and X-ray crystallography.
Aldrich is featured in the HealthTalk story, "Promising research for a new antibiotic" discussing a study method that has the potential to unlock significantly more antibiotics.
A new St. Paul-based company that is developing drug therapies that will make cancer treatments more effective is based on scientific discoveries by Harki.
Department News Feed
Graduate students receive a diverse educational experience in chemistry and biology that prepares them for the evolving multidisciplinary research of the pharmaceutical industry and academic biomedical arena.
The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action.
The mission of the ITDD is to carry out interdisciplinary research, help educate the next generation of scientists, and to enhance the biomedical research infrastructure at the University of Minnesota by creating opportunities for drug discovery and early pre-clinical drug development.